StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30498% above fair value
$32.50−0.18 (-0.55%)

Close on Nov 17, 2026Market cap $152.14MP/E –Yield –

Korsana Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Korsana Biosciences's enterprise value was $134.13M on Nov 11, 2026, against -$123.01M a year earlier. Over the last 5 years it ranged from -$142.38M to $458.94M, with a median of $55.59M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$134.13M–
2025Dec 31, 2025-$131.03M-341.9%
2024Dec 31, 2024$54.17M+12.3%
2023Dec 29, 2023$48.23M-73.1%
2022Dec 30, 2022$179.38M-60.9%
2021Dec 31, 2021$458.94M-30.9%
2020Dec 31, 2020$664.10M+63.6%
2019Dec 31, 2019$405.95M–

More Korsana Biosciences figures

See a number that looks wrong?